Laminin-211 in skeletal muscle function

Cell Adhesion and Migration

Volumn 7, Issue 1, 2013, Pages 111-121

  Holmberg, Johan ^a   Durbeej, Madeleine ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Basement membrane; Dystroglycan; Integrin; Laminin; Muscle force; Sarcolemma; Skeletal muscle

Indexed keywords

CYTOSKELETON PROTEIN; GLYCOPROTEIN; LAMININ; LAMININ 211; UNCLASSIFIED DRUG;

BASEMENT MEMBRANE; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; EXTRACELLULAR MATRIX; MUSCLE FUNCTION; MUSCULAR DYSTROPHY; NONHUMAN; REVIEW; SKELETAL MUSCLE;

EID: 84872194435     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.22618     Document Type: Review

References (111)

1. Huxley AF, Simmons RM. Proposed mechanism of force generation in striated muscle. Nature 1971; 233:533-8; PMID:4939977; http://dx.doi.org/10.1038/ 233533a0
2. Squire JM. Architecture and function in the muscle sarcomere. Curr Opin Struct Biol 1997; 7:247-57; PMID:9094325; http://dx.doi.org/10.1016/S0959- 440X(97)80033-4
3. Engel AG. Franzini-Armstrong C, ed. Myology: McGraw-Hill, 2004.
4. Hoppeler H, Flück M. Normal mammalian skeletal muscle and its phenotypic plasticity. J Exp Biol 2002; 205:2143-52; PMID:12110647
5. Purslow PP. The structure and functional significance of variations in the connective tissue within muscle. Comp Biochem Physiol A Mol Integr Physiol 2002; 133:947-66; PMID:12485685; http://dx.doi.org/10.1016/S1095-6433(02)00141-1
6. Tidball JG. Force transmission across muscle cell membranes. J Biomech 1991; 24(Suppl 1):43-52; PMID:1791181; http://dx.doi.org/10.1016/0021-9290(91) 90376-X
7. Sanes JR. The basement membrane/basal lamina of skeletal muscle. J Biol Chem 2003; 278:12601-4; PMID:12556454; http://dx.doi.org/10.1074/jbc.R200027200
8. Yurchenco PD, Patton BL. Developmental and pathogenic mechanisms of basement membrane assembly. Curr Pharm Des 2009; 15:1277-94; PMID:19355968; http://dx.doi.org/10.2174/138161209787846766
9. Sasaki T, Giltay R, Talts U, Timpl R, Talts JF. Expression and distribution of laminin alpha1 and alpha2 chains in embryonic and adult mouse tissues: an immunochemical approach. Exp Cell Res 2002; 275:185-99; PMID:11969289; http://dx.doi.org/10.1006/excr.2002.5499
10. Ehrig K, Leivo I, Argraves WS, Ruoslahti E, Engvall E. Merosin, a tissue-specific basement membrane protein, is a laminin-like protein. Proc Natl Acad Sci U S A 1990; 87:3264-8; PMID:2185464; http://dx.doi.org/10.1073/pnas.87. 9.3264
11. Patton BL, Miner JH, Chiu AY, Sanes JR. Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice. J Cell Biol 1997; 139:1507-21; PMID:9396756; http://dx.doi.org/10.1083/jcb.139.6. 1507
12. Timpl R, Rohde H, Robey PG, Rennard SI, Foidart JM, Martin GR. Laminin-a glycoprotein from basement membranes. J Biol Chem 1979; 254:9933-7; PMID:114518
13. Chung AE, Jaffe R, Freeman IL, Vergnes JP, Braginski JE, Carlin B. Properties of a basement membrane-related glycoprotein synthesized in culture by a mouse embryonal carcinoma-derived cell line. Cell 1979; 16:277-87; PMID:88263; http://dx.doi.org/10.1016/0092-8674(79)90005-9
14. Engel J, Odermatt E, Engel A, Madri JA, Furthmayr H, Rohde H, et al. Shapes, domain organizations and flexibility of laminin and fibronectin, two multifunctional proteins of the extracellular matrix. J Mol Biol 1981; 150:97-120; PMID:6795355; http://dx.doi.org/10.1016/0022-2836(81)90326-0
15. Durbeej M. Laminins. Cell Tissue Res 2010; 339:259-68; PMID:19693542; http://dx.doi.org/10.1007/s00441-009-0838-2
16. Cheng YS, Champliaud MF, Burgeson RE, Marinkovich MP, Yurchenco PD. Self-assembly of laminin isoforms. J Biol Chem 1997; 272:31525-32; PMID:9395489; http://dx.doi.org/10.1074/jbc.272.50.31525
17. Colognato H, Winkelmann DA, Yurchenco PD. Laminin polymerization induces a receptor-cytoskeleton network. J Cell Biol 1999; 145:619-31; PMID:10225961; http://dx.doi.org/10.1083/jcb.145.3.619
18. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110:673-87; PMID:12297042; http://dx.doi.org/10.1016/S0092-8674(02)00971-6
19. Song WK, Wang W, Foster RF, Bielser DA, Kaufman SJ. H36-alpha 7 is a novel integrin alpha chain that is developmentally regulated during skeletal myogenesis. J Cell Biol 1992; 117:643-57; PMID:1315319; http://dx.doi.org/10. 1083/jcb.117.3.643
20. Burkin DJ, Kaufman SJ. The alpha7beta1 integrin in muscle development and disease. Cell Tissue Res 1999; 296:183-90; PMID:10199978; http://dx.doi.org/10. 1007/s004410051279
21. Mayer U. Integrins: redundant or important players in skeletal muscle? J Biol Chem 2003; 278:14587-90; PMID:12556453; http://dx.doi.org/10.1074/jbc. R200022200
22. Ziober BL, Vu MP, Waleh N, Crawford J, Lin CS, Kramer RH. Alternative extracellular and cytoplasmic domains of the integrin alpha 7 subunit are differentially expressed during development. J Biol Chem 1993; 268:26773-83; PMID:8253814
23. Ervasti JM, Campbell KP. Membrane organization of the dystrophin-glycoprotein complex. Cell 1991; 66:1121-31; PMID:1913804; http://dx.doi.org/10.1016/0092-8674(91)90035-W
24. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 1992; 355:696-702; PMID:1741056; http://dx.doi.org/10.1038/355696a0
25. Nguyen TM, Ellis JM, Love DR, Davies KE, Gatter KC, Dickson G, et al. Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. J Cell Biol 1991; 115:1695-700; PMID:1757469; http://dx.doi.org/10.1083/jcb.115.6.1695
26. Tinsley JM, Blake DJ, Roche A, Fairbrother U, Riss J, Byth BC, et al. Primary structure of dystrophin-related protein. Nature 1992; 360:591-3; PMID:1461283; http://dx.doi.org/10.1038/360591a0
27. Ibraghimov-Beskrovnaya O, Milatovich A, Ozcelik T, Yang B, Koepnick K, Francke U, et al. Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum Mol Genet 1993; 2:1651-7; PMID:8268918; http://dx.doi.org/10.1093/hmg/2.10.1651
28. Barresi R, Campbell KP. Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci 2006; 119:199-207; PMID:16410545; http://dx.doi.org/10.1242/jcs.02814
29. Yoshida-Moriguchi T, Yu L, Stalnaker SH, Davis S, Kunz S, Madson M, et al. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science 2010; 327:88-92; PMID:20044576; http://dx.doi.org/10.1126/ science.1180512
30. Inamori K, Yoshida-Moriguchi T, Hara Y, Anderson ME, Yu L, Campbell KP. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science 2012; 335:93-6; PMID:22223806; http://dx.doi.org/10.1126/science. 1214115
31. Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993; 122:809-23; PMID:8349731; http://dx.doi.org/10.1083/jcb.122.4.809
32. Crosbie RH, Lebakken CS, Holt KH, Venzke DP, Straub V, Lee JC, et al. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. J Cell Biol 1999; 145:153-65; PMID:10189375; http://dx.doi.org/10. 1083/jcb.145.1.153
33. Talts JF, Andac Z, Göhring W, Brancaccio A, Timpl R. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins. EMBO J 1999; 18:863-70; PMID:10022829; http://dx.doi.org/10.1093/emboj/18.4.863
34. Suzuki N, Yokoyama F, Nomizu M. Functional sites in the laminin alpha chains. Connect Tissue Res 2005; 46:142-52; PMID:16147852; http://dx.doi.org/10. 1080/03008200591008527
35. Smirnov SP, McDearmon EL, Li S, Ervasti JM, Tryggvason K, Yurchenco PD. Contributions of the LG modules and furin processing to laminin-2 functions. J Biol Chem 2002; 277:18928-37; PMID:11886875; http://dx.doi.org/10.1074/jbc. M201880200
36. Suzuki N, Nakatsuka H, Mochizuki M, Nishi N, Kadoya Y, Utani A, et al. Biological activities of homologous loop regions in the laminin alpha chain G domains. J Biol Chem 2003; 278:45697-705; PMID:12933811; http://dx.doi.org/10. 1074/jbc.M304667200
37. Timpl R, Tisi D, Talts JF, Andac Z, Sasaki T, Hohenester E. Structure and function of laminin LG modules. Matrix Biol 2000; 19:309-17; PMID:10963991; http://dx.doi.org/10.1016/S0945-053X(00)00072-X
38. Ido H, Nakamura A, Kobayashi R, Ito S, Li S, Futaki S, et al. The requirement of the glutamic acid residue at the third position from the carboxyl termini of the laminin gamma chains in integrin binding by laminins. J Biol Chem 2007; 282:11144-54; PMID:17307733; http://dx.doi.org/10.1074/jbc.M609402200
39. Carafoli F, Clout NJ, Hohenester E. Crystal structure of the LG1-3 region of the laminin alpha2 chain. J Biol Chem 2009; 284:22786-92; PMID:19553699; http://dx.doi.org/10.1074/jbc.M109.026658
40. Mayer U, Kohfeldt E, Timpl R. Structural and genetic analysis of laminin-nidogen interaction. Ann N Y Acad Sci 1998; 857:130-42; PMID:9917838; http://dx.doi.org/10.1111/j.1749-6632.1998.tb10113.x
41. Iozzo RV, Cohen IR, Grässel S, Murdoch AD. The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem J 1994; 302:625-39; PMID:7945186
42. Carmignac V, Durbeej M. Cell-matrix interactions in muscle disease. J Pathol 2012; 226:200-18; PMID:21989954; http://dx.doi.org/10.1002/path.3020
43. Bezakova G, Ruegg MA. New insights into the roles of agrin. Nat Rev Mol Cell Biol 2003; 4:295-308; PMID:12671652; http://dx.doi.org/10.1038/nrm1074
44. Zoeller JJ, McQuillan A, Whitelock J, Ho SY, Iozzo RV. A central function for perlecan in skeletal muscle and cardiovascular development. J Cell Biol 2008; 181:381-94; PMID:18426981; http://dx.doi.org/10.1083/jcb.200708022
45. Xu Z, Ichikawa N, Kosaki K, Yamada Y, Sasaki T, Sakai LY, et al. Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber composition. Matrix Biol 2010; 29:461-70; PMID:20541011; http://dx.doi.org/10.1016/j.matbio.2010.06.001
46. Labelle-Dumais C, Dilworth DJ, Harrington EP, de Leau M, Lyons D, Kabaeva Z, et al. COL4A1 mutations cause ocular dysgenesis, neuronal localization defects, and myopathy in mice and Walker-Warburg syndrome in humans. PLoS Genet 2011; 7:e1002062; PMID:21625620; http://dx.doi.org/10.1371/journal.pgen.1002062
47. Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J, et al. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995; 11:216-8; PMID:7550355; http://dx.doi.org/10.1038/ng1095-216
48. Mostacciuolo ML, Miorin M, Martinello F, Angelini C, Perini P, Trevisan CP. Genetic epidemiology of congenital muscular dystrophy in a sample from northeast Italy. Hum Genet 1996; 97:277-9; PMID:8786062; http://dx.doi.org/10. 1007/BF02185752
49. Darin N, Tulinius M. Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden. Neuromuscul Disord 2000; 10:1-9; PMID:10677857; http://dx.doi.org/10.1016/S0960-8966(99)00055-3
50. Allamand V, Guicheney P. Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin). Eur J Hum Genet 2002; 10:91-4; PMID:11938437; http://dx.doi.org/10. 1038/sj.ejhg.5200743
51. Nissinen M, Helbling-Leclerc A, Zhang X, Evangelista T, Topaloglu H, Cruaud C, et al. Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin alpha2-chain in congenital muscular dystrophy with partial deficiency of the protein. Am J Hum Genet 1996; 58:1177-84; PMID:8651294
52. Allamand V, Sunada Y, Salih MA, Straub V, Ozo CO, Al-Turaiki MH, et al. Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain. Hum Mol Genet 1997; 6:747-52; PMID:9158149; http://dx.doi.org/10.1093/hmg/6.5.747
53. Guo LT, Zhang XU, Kuang W, Xu H, Liu LA, Vilquin JT, et al. Laminin alpha2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice. Neuromuscul Disord 2003; 13:207-15; PMID:12609502; http://dx.doi.org/10.1016/s0960-8966(02)00266-3
54. Shelton GD, Liu LA, Guo LT, Smith GK, Christiansen JS, Thomas WB, et al. Muscular dystrophy in female dogs. J Vet Intern Med 2001; 15:240-4; PMID:11380033; http://dx.doi.org/10.1111/j.1939-1676.2001.tb02317.x
55. O'Brien DP, Johnson GC, Liu LA, Guo LT, Engvall E, Powell HC, et al. Laminin alpha 2 (merosin)-deficient muscular dystrophy and demyelinating neuropathy in two cats. J Neurol Sci 2001; 189:37-43; PMID:11535231; http://dx.doi.org/10.1016/S0022-510X(01)00559-7
56. Xu H, Wu XR, Wewer UM, Engvall E. Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene. Nat Genet 1994; 8:297-302; PMID:7874173; http://dx.doi.org/10.1038/ng1194-297
57. Xu H, Christmas P, Wu XR, Wewer UM, Engvall E. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci U S A 1994; 91:5572-6; PMID:8202529; http://dx.doi.org/10.1073/pnas.91.12.5572
58. Miyagoe Y, Hanaoka K, Nonaka I, Hayasaka M, Nabeshima Y, Arahata K, et al. Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett 1997; 415:33-9; PMID:9326364; http://dx.doi.org/10.1016/ S0014-5793(97)01007-7
59. Kuang W, Xu H, Vachon PH, Liu L, Loechel F, Wewer UM, et al. Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models. J Clin Invest 1998; 102:844-52; PMID:9710454; http://dx.doi.org/10.1172/JCI3705
60. Patton BL, Wang B, Tarumi YS, Seburn KL, Burgess RW. A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination. J Cell Sci 2008; 121:1593-604; PMID:18430779; http://dx.doi.org/ 10.1242/jcs.015354
61. Gawlik KI, Durbeej M. Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies. Skelet Muscle 2011; 1:9; PMID:21798088; http://dx.doi.org/10.1186/2044-5040-1-9
62. Hoffman EP, Brown RH, Jr., Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51:919-28; PMID:3319190; http://dx.doi.org/10.1016/0092-8674(87)90579-4
63. Guglieri M, Magri F, Comi GP. Molecular etiopathogenesis of limb girdle muscular and congenital muscular dystrophies: boundaries and contiguities. Clin Chim Acta 2005; 361:54-79; PMID:16002060; http://dx.doi.org/10.1016/j.cccn.2005. 05.020
64. Gillis JM. Membrane abnormalities and Ca homeostasis in muscles of the mdx mouse, an animal model of the Duchenne muscular dystrophy: a review. Acta Physiol Scand 1996; 156:397-406; PMID:8729700; http://dx.doi.org/10.1046/j.1365- 201X.1996.201000.x
65. Claflin DR, Brooks SV. Direct observation of failing fibers in muscles of dystrophic mice provides mechanistic insight into muscular dystrophy. Am J Physiol Cell Physiol 2008; 294:C651-8; PMID:18171725; http://dx.doi.org/10.1152/ ajpcell.00244.2007
66. Straub V, Rafael JA, Chamberlain JS, Campbell KP. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 1997; 139:375-85; PMID:9334342; http://dx.doi.org/10.1083/jcb.139.2.375
67. Gawlik KI, Akerlund M, Carmignac V, Elamaa H, Durbeej M. Distinct roles for laminin globular domains in laminin alpha1 chain mediated rescue of murine laminin alpha2 chain deficiency. PLoS One 2010; 5:e11549; PMID:20657839; http://dx.doi.org/10.1371/journal.pone.0011549
68. Hall TE, Bryson-Richardson RJ, Berger S, Jacoby AS, Cole NJ, Hollway GE, et al. The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy. Proc Natl Acad Sci U S A 2007; 104:7092-7; PMID:17438294; http://dx.doi.org/10.1073/pnas. 0700942104
69. Tomé FM, Evangelista T, Leclerc A, Sunada Y, Manole E, Estournet B, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III 1994; 317:351-7; PMID:8000914
70. Rybakova IN, Patel JR, Ervasti JM. The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin. J Cell Biol 2000; 150:1209-14; PMID:10974007; http://dx.doi.org/10.1083/jcb.150.5.1209
71. Goldstein JA, McNally EM. Mechanisms of muscle weakness in muscular dystrophy. J Gen Physiol 2010; 136:29-34; PMID:20584890; http://dx.doi.org/10. 1085/jgp.201010436
72. Grewal PK, Holzfeind PJ, Bittner RE, Hewitt JE. Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse. Nat Genet 2001; 28:151-4; PMID:11381262; http://dx.doi.org/10.1038/88865
73. Lane PW, Beamer TC, Myers DD. Myodystrophy, a new myopathy on chromosome 8 of the mouse. J Hered 1976; 67:135-8; PMID:939913
74. Han R, Kanagawa M, Yoshida-Moriguchi T, Rader EP, Ng RA, Michele DE, et al. Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proc Natl Acad Sci U S A 2009; 106:12573-9; PMID:19633189; http://dx.doi.org/10.1073/pnas.0906545106
75. Holzfeind PJ, Grewal PK, Reitsamer HA, Kechvar J, Lassmann H, Hoeger H, et al. Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse defines a natural model for glycosylation-deficient muscle - eye - brain disorders. Hum Mol Genet 2002; 11:2673-87; PMID:12354792; http://dx.doi.org/10.1093/hmg/11.21. 2673
76. Gumerson JD, Kabaeva ZT, Davis CS, Faulkner JA, Michele DE. Soleus muscle in glycosylation-deficient muscular dystrophy is protected from contraction-induced injury. Am J Physiol Cell Physiol 2010; 299:C1430-40; PMID:20844247; http://dx.doi.org/10.1152/ajpcell.00192.2010
77. Hodges BL, Hayashi YK, Nonaka I, Wang W, Arahata K, Kaufman SJ. Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies. J Cell Sci 1997; 110:2873-81; PMID:9427295
78. Ringelmann B, Röder C, Hallmann R, Maley M, Davies M, Grounds M, et al. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice. Exp Cell Res 1999; 246:165-82; PMID:9882526; http://dx.doi.org/10.1006/excr. 1998.4244
79. Talts JF, Sasaki T, Miosge N, Göhring W, Mann K, Mayne R, et al. Structural and functional analysis of the recombinant G domain of the laminin alpha4 chain and its proteolytic processing in tissues. J Biol Chem 2000; 275:35192-9; PMID:10934193; http://dx.doi.org/10.1074/jbc.M003261200
80. Moll J, Barzaghi P, Lin S, Bezakova G, Lochmüller H, Engvall E, et al. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature 2001; 413:302-7; PMID:11565031; http://dx.doi.org/10.1038/35095054
81. Meinen S, Lin S, Thurnherr R, Erb M, Meier T, Rüegg MA. Apoptosis inhibitors and mini-agrin have additive benefits in congenital muscular dystrophy mice. EMBO Mol Med 2011; 3:465-79; PMID:21674808; http://dx.doi.org/ 10.1002/emmm.201100151
82. Gawlik K, Miyagoe-Suzuki Y, Ekblom P, Takeda S, Durbeej M. Laminin alpha1 chain reduces muscular dystrophy in laminin alpha2 chain deficient mice. Hum Mol Genet 2004; 13:1775-84; PMID:15213105; http://dx.doi.org/10.1093/hmg/ddh190
83. Rooney JE, Gurpur PB, Burkin DJ. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 2009; 106:7991-6; PMID:19416897; http://dx.doi.org/10.1073/pnas. 0811599106
84. Rooney JE, Knapp JR, Hodges BL, Wuebbles RD, Burkin DJ. Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy. Am J Pathol 2012; 180:1593-602; PMID:22322301; http://dx.doi.org/10.1016/j.ajpath.2011.12.019
85. Goudenege S, Lamarre Y, Dumont N, Rousseau J, Frenette J, Skuk D, et al. Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy. Mol Ther 2010; 18:2155-63; PMID:20683444; http://dx.doi.org/10.1038/mt.2010.165
86. Gawlik KI, Oliveira BM, Durbeej M. Transgenic expression of Laminin a1 chain does not prevent muscle disease in the mdx mouse model for Duchenne muscular dystrophy. Am J Pathol 2011; 178:1728-37; PMID:21435454; http://dx.doi.org/10.1016/j.ajpath.2010.12.030
87. Suh JH, Jarad G, VanDeVoorde RG, Miner JH. Forced expression of laminin beta1 in podocytes prevents nephrotic syndrome in mice lacking laminin beta2, a model for Pierson syndrome. Proc Natl Acad Sci U S A 2011; 108:15348-53; PMID:21876163; http://dx.doi.org/10.1073/pnas.1108269108
88. Boppart MD, Burkin DJ, Kaufman SJ. Alpha7beta1-integrin regulates mechanotransduction and prevents skeletal muscle injury. Am J Physiol Cell Physiol 2006; 290:C1660-5; PMID:16421207; http://dx.doi.org/10.1152/ajpcell. 00317.2005
89. Liu J, Milner DJ, Boppart MD, Ross RS, Kaufman SJ. β1D chain increases α7β1 integrin and laminin and protects against sarcolemmal damage in mdx mice. Hum Mol Genet 2012; 21:1592-603; PMID:22180459; http://dx.doi.org/10.1093/hmg/ddr596
90. Boppart MD, Burkin DJ, Kaufman SJ. Activation of AKT signaling promotes cell growth and survival in α7β1 integrin-mediated alleviation of muscular dystrophy. Biochim Biophys Acta 2011; 1812:439-46; PMID:21216283; http://dx.doi.org/10.1016/j.bbadis.2011.01.002
91. Vachon PH, Xu H, Liu L, Loechel F, Hayashi Y, Arahata K, et al. Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy. J Clin Invest 1997; 100:1870-81; PMID:9312189; http://dx.doi.org/10.1172/JCI119716
92. Laprise P, Vallée K, Demers MJ, Bouchard V, Poirier EM, Vézina A, et al. Merosin (laminin-2/4)-driven survival signaling: complex modulations of Bcl-2 homologs. J Cell Biochem 2003; 89:1115-25; PMID:12898510; http://dx.doi.org/10.1002/jcb.10581
93. Hayashi YK, Tezak Z, Momoi T, Nonaka I, Garcia CA, Hoffman EP, et al. Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy. Neuromuscul Disord 2001; 11:350-9; PMID:11369186; http://dx.doi.org/10.1016/S0960-8966(00)00203-0
94. Girgenrath M, Dominov JA, Kostek CA, Miller JB. Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy. J Clin Invest 2004; 114:1635-9; PMID:15578095
95. Girgenrath M, Beermann ML, Vishnudas VK, Homma S, Miller JB. Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy. Ann Neurol 2009; 65:47-56; PMID:19086074; http://dx.doi.org/10.1002/ ana.21523
96. Carmignac V, Svensson M, Körner Z, Elowsson L, Matsumura C, Gawlik KI, et al. Autophagy is increased in laminin a2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A. Hum Mol Genet 2011; 20:4891-902; PMID:21920942; http://dx.doi.org/10.1093/hmg/ddr427
97. Carmignac V, Quéré R, Durbeej M. Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice. Hum Mol Genet 2011; 20:541-52; PMID:21084425; http://dx.doi.org/10.1093/hmg/ddq499
98. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004; 117:399-412; PMID:15109499; http://dx.doi.org/10.1016/S0092-8674(04)00400-3
99. Léger B, Cartoni R, Praz M, Lamon S, Dériaz O, Crettenand A, et al. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. J Physiol 2006; 576:923-33; PMID:16916907; http://dx.doi.org/10.1113/jphysiol.2006.116715
100. Gawlik KI, Mayer U, Blomberg K, Sonnenberg A, Ekblom P, Durbeej M. Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan. FEBS Lett 2006; 580:1759-65; PMID:16504180; http://dx.doi.org/10.1016/j.febslet.2006.02. 027
101. Pardo JV, Siliciano JD, Craig SW. A vinculin-containing cortical lattice in skeletal muscle: transverse lattice elements ("costameres") mark sites of attachment between myofibrils and sarcolemma. Proc Natl Acad Sci U S A 1983; 80:1008-12; PMID:6405378; http://dx.doi.org/10.1073/pnas.80.4.1008
102. Bloch RJ, Gonzalez-Serratos H. Lateral force transmission across costameres in skeletal muscle. Exerc Sport Sci Rev 2003; 31:73-8; PMID:12715970; http://dx.doi.org/10.1097/00003677-200304000-00004
103. Ervasti JM. Costameres: the Achilles' heel of Herculean muscle. J Biol Chem 2003; 278:13591-4; PMID:12556452; http://dx.doi.org/10.1074/jbc.R200021200
104. Street SF. Lateral transmission of tension in frog myofibers: a myofibrillar network and transverse cytoskeletal connections are possible transmitters. J Cell Physiol 1983; 114:346-64; PMID:6601109; http://dx.doi.org/10.1002/jcp.1041140314
105. Young M, Paul A, Rodda J, Duxson M, Sheard P. Examination of intrafascicular muscle fiber terminations: implications for tension delivery in series-fibered muscles. J Morphol 2000; 245:130-45; PMID:10906747; http://dx.doi.org/10.1002/1097-4687(200008)245:2〈130::AID-JMOR4〈3.0. CO;2-R
106. Paul AC, Sheard PW, Kaufman SJ, Duxson MJ. Localization of alpha 7 integrins and dystrophin suggests potential for both lateral and longitudinal transmission of tension in large mammalian muscles. Cell Tissue Res 2002; 308:255-65; PMID:12037582; http://dx.doi.org/10.1007/s00441-002-0526-y
107. Ramaswamy KS, Palmer ML, van der Meulen JH, Renoux A, Kostrominova TY, Michele DE, et al. Lateral transmission of force is impaired in skeletal muscles of dystrophic mice and very old rats. J Physiol 2011; 589:1195-208; PMID:21224224; http://dx.doi.org/10.1113/jphysiol.2010.201921
108. Bian W, Bursac N. Tissue engineering of functional skeletal muscle: challenges and recent advances. IEEE Eng Med Biol Mag 2008; 27:109-13; PMID:18799400
109. Hinds S, Bian W, Dennis RG, Bursac N. The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle. Biomaterials 2011; 32:3575-83; PMID:21324402; http://dx.doi.org/10.1016/j. biomaterials.2011.01.062
110. Kuang W, Xu H, Vilquin JT, Engvall E. Activation of the lama2 gene in muscle regeneration: abortive regeneration in laminin alpha2-deficiency. Lab Invest 1999; 79:1601-13; PMID:10616210
111. Bentzinger CF, Barzaghi P, Lin S, Ruegg MA. Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice. FASEB J 2005; 19:934-42; PMID:15923403; http://dx.doi.org/10.1096/fj.04-3376com